XU CHERYL purchased 31.6% of their position (13K shares) of 60 DEGREES PHARMACEUTICALS, INC. on the open market
Open‑market purchase worth $21.4K — a major conviction buy. The strongest form of insider conviction signal.
Common Stock
Shares
+2.50K
Price / share
$1.85
Trade value
$4.63K
% of position
Common Stock
Shares
+2.50K
Price / share
$1.80
Trade value
$4.50K
% of position
Common Stock
Shares
+1.50K
Price / share
$1.60
Trade value
$2.40K
% of position
Common Stock
Shares
+1.50K
Price / share
$1.58
Trade value
$2.37K
% of position
Common Stock
Shares
+1.50K
Price / share
$1.55
Trade value
$2.33K
% of position
Common Stock
Shares
+1.50K
Price / share
$1.52
Trade value
$2.28K
% of position
Common Stock
Shares
+2K
Price / share
$1.45
Trade value
$2.90K
% of position
Net shares
+13K
Net value
$21.40K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/12/2024 | P · Purchase | +2.50K | $1.85 | $4.63K | 6.1% | 41.08K | 43.58K |
| Common Stock Direct | 12/12/2024 | P · Purchase | +2.50K | $1.80 | $4.50K | 5.7% | 43.58K | 46.08K |
| Common Stock Direct | 12/13/2024 | P · Purchase | +1.50K | $1.60 | $2.40K | 3.3% | 46.08K | 47.58K |
| Common Stock Direct | 12/13/2024 | P · Purchase | +1.50K | $1.58 | $2.37K | 3.2% | 47.58K | 49.08K |
| Common Stock Direct | 12/13/2024 | P · Purchase | +1.50K | $1.55 | $2.33K | 3.1% | 49.08K | 50.58K |
| Common Stock Direct | 12/13/2024 | P · Purchase | +1.50K | $1.52 | $2.28K | 3.0% | 50.58K | 52.08K |
| Common Stock Direct | 12/16/2024 | P · Purchase | +2K | $1.45 | $2.90K | 3.8% | 52.08K | 54.08K |
| Total | +13K | $21.40K | ||||||